Skip to main content
. 2017 Apr 25;18(5):903. doi: 10.3390/ijms18050903

Figure 1.

Figure 1

Schematic diagram of preparing 188Re-liposome. The manufacturing process includes embedment of liposome and 188Re-perrhenate. The final product would be aliquoted into vials in 10 ± 2 mCi per 1 mL in the phase I trial. BMEDA, N,N-bis(2-mercaptoethyl)-N9,N9-diethylethylenediamine.